Pegasus Pharmaceuticals Inc · 66-41 · CANADA
For Pegasus Pharmaceuticals Inc, import alert is 66-41; country is CANADA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Careseng #1 (Capsules & Liquids) | Careseng #2; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is #156-11786 River Rd , Richmond, BC CANADA, verified against its source on 2026-10-01.
- Firm
- Pegasus Pharmaceuticals Inc verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CANADA verified
- Address
- #156-11786 River Rd , Richmond, BC CANADA verified
- Date published
- 09/30/2009 verified
- Product code
- 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Careseng #1 (Capsules & Liquids) | Careseng #2 each item verified
- FDA notes
- 1/15/2004 | 3/1/2004 each item verified
What the source says
Pegasus Pharmaceuticals Inc Date Published : 09/30/2009 #156-11786 River Rd , Richmond, BC CANADA
— accessdata.fda.gov, retrieved 2026-09-24
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/20/2019 Desc: Careseng #1 (Capsules & Liquids) Notes: 1/15/2004 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/20/2019 Desc: Careseng #2 Notes: 3/1/2004
— all from accessdata.fda.gov, retrieved 2026-09-24
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.